DEF 14AThe Ballot
Xeris Biopharma Holdings, Inc. files DEF 14A
Filed Apr 23, 2026 · 2mo ago · Accession 0001867096-26-000021
Plain English
Proxy statement — executive pay, board nominees, and shareholder votes.
Read the source below for the full document.
Filing details
- Ticker
- XERS
- CIK
- 1867096
- Form type
- DEF 14A
- Filing date
- Apr 23, 2026
- Report date
- Dec 31, 2025
- Document
- xers-20260423.htm
- Size
- 6.4 MB